Lymphocytic alveolitis and radiologic bronchiolitis obliterans-organizing pneumonia were the key findings in this series of 24 patients who had renal transplantation and developed sirolimus-associated pneumonitis. Sirolimus withdrawal was associated with recovery within 6 months
AbstractObjectivesReport a case of sirolimus induced granulomatous pneumonitis.BackgroundSirolimus i...
Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairm...
We conducted a pilot open-label study on the use of sirolimus in 10 Chinese patients undergoing kidn...
Background: Interstitial pneumonitis is an ill-defined side effect of sirolimus, a new immunosuppres...
PURPOSE: Sirolimus is a potent immunosuppressive agent used with increasing frequency in kidney tran...
Sirolimus-associated pneumonitis, a rare but serious drug-induced lung injury, has become a great co...
A 64 year-old man, who received a renal transplant in 1988 for end-stage renal disease due to chroni...
Item does not contain fulltextThe use of inhibitors of the mammalian target of rapamycin (mTORi) in ...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
International audienceIntroductionSirolimus is an immunosupressant used in renal transplantation bec...
BACKGROUND: Standard immunosuppression after lung transplantation includes calcineurin inhibitors, a...
AbstractDrug induced lung diseases (DILD) are an increasingly cause of morbidity. Many drugs have be...
Goal of Case report: Presentation of PCP \u3e1-year post-transplant and role of prophylaxis and immu...
Transpl Int. 2007 Mar;20(3):291-6. Pulmonary alveolar proteinosis: a rare pulmonary toxicity of s...
The mTOR inhibitors (mTORi, mammalian target of rapamycin; sirolimus and everolimus) have been recen...
AbstractObjectivesReport a case of sirolimus induced granulomatous pneumonitis.BackgroundSirolimus i...
Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairm...
We conducted a pilot open-label study on the use of sirolimus in 10 Chinese patients undergoing kidn...
Background: Interstitial pneumonitis is an ill-defined side effect of sirolimus, a new immunosuppres...
PURPOSE: Sirolimus is a potent immunosuppressive agent used with increasing frequency in kidney tran...
Sirolimus-associated pneumonitis, a rare but serious drug-induced lung injury, has become a great co...
A 64 year-old man, who received a renal transplant in 1988 for end-stage renal disease due to chroni...
Item does not contain fulltextThe use of inhibitors of the mammalian target of rapamycin (mTORi) in ...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
International audienceIntroductionSirolimus is an immunosupressant used in renal transplantation bec...
BACKGROUND: Standard immunosuppression after lung transplantation includes calcineurin inhibitors, a...
AbstractDrug induced lung diseases (DILD) are an increasingly cause of morbidity. Many drugs have be...
Goal of Case report: Presentation of PCP \u3e1-year post-transplant and role of prophylaxis and immu...
Transpl Int. 2007 Mar;20(3):291-6. Pulmonary alveolar proteinosis: a rare pulmonary toxicity of s...
The mTOR inhibitors (mTORi, mammalian target of rapamycin; sirolimus and everolimus) have been recen...
AbstractObjectivesReport a case of sirolimus induced granulomatous pneumonitis.BackgroundSirolimus i...
Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairm...
We conducted a pilot open-label study on the use of sirolimus in 10 Chinese patients undergoing kidn...